• <th id="abimu"></th>

      1. 產(chǎn)品中心

        Recombinant Human IL-17A
        EPT053
        規(guī)格: 價格:
        10μg ¥600.00

        Overview

        Product name: Recombinant Human IL-17A
        Description: Recombinant Human Interleukin-17A is produced by our E.coli expression system and the target gene encoding Gly24-Ala155 is expressed.
        Accession: Q16552
        Molecular weight: 15.26 KDa
        Apparent molecular weight: 16 KDa, reducing conditions
        Purity: Greater than 95% as determined by reducing SDS-PAGE.
        Endotoxin: Less than 0.1 ng/μg (1 EU/μg) as determined by LAL test.
        Biological activity: Immobilized Human IL-17A(Cat#C021) at 2μg/ml (100 μl/well) can bind Anti-Human IL-17A mAb(Cat#NC012).The ED50 of Anti-Human IL-17A mAb(Cat#NC012) is 0.185 ug/ml.
        Redissolve: Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.?
        Storage: Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
        Delivery condition: The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below.
        Background: Interleukin-17 is a potent pro-inflammatory cytokine produced by activated memory T cells. There are at least six members of the IL-17 family in humans and in mice. As IL-17 shares properties with IL-1 and TNF-alpha, it may induce joint inflammation and bone and cartilage destruction. This cytokine is found in synovial fluids of patients with rheumatoid arthritis, and produced by rheumatoid arthritis synovium. It increases IL-6 production, induces collagen degradation and decreases collagen synthesis by synovium and cartilage and proteoglycan synthesis in cartilage. IL-17 is also able to increase bone destruction and reduce its formation. Blocking of interleukin-17 with specific inhibitors provides a protective inhibition of cartilage and bone degradation.
        關閉

        在線咨詢

        Online consultation

        • 在線咨詢
        • 技術支持

        關注微信公眾號

        微信掃一掃立即咨詢

        微信掃一掃立即咨詢

        關閉
        一级a爱片国产亚洲精品,97se亚洲综合色区,日朝欧美亚洲精品,欧洲韩国亚洲一区二区三区

      2. <th id="abimu"></th>